このページの翻訳は実験的なもので、現在開発中です。お待ちしております
Emergent BioSolutions マネジメント
マネジメント 基準チェック /14
現在、CEO に関する十分な情報がありません。
主要情報
Joe Papa
最高経営責任者
n/a
報酬総額
| CEO給与比率 | n/a |
| CEO在任期間 | less than a year |
| CEOの所有権 | n/a |
| 経営陣の平均在職期間 | 1.6yrs |
| 取締役会の平均在任期間 | 3.2yrs |
経営陣の近況
Recent updates
Little Excitement Around Emergent BioSolutions Inc.'s (NYSE:EBS) Revenues As Shares Take 27% Pounding
Sep 16
Emergent BioSolutions: Speculative Buy Amid Potential Monkeypox Vaccine Approval
Aug 18Emergent BioSolutions Inc. (NYSE:EBS) Held Back By Insufficient Growth Even After Shares Climb 41%
Aug 02Emergent BioSolutions: A Much-Needed Mid-Stage Turnaround In Process
Jul 15Emergent BioSolutions: High-Risk, High-Reward Strategic Turnaround
May 10New CEO Appointment A Clear Positive For Emergent BioSolutions
Feb 27Emergent BioSolutions: Q3 Numbers Leave Work To Be Done
Dec 18Emergent BioSolutions: Meaningful Debt, But Narcan Should Grow
Nov 23Emergent BioSolutions Is Clearly Risky, But The Reward Could Be Substantial
Aug 23Financial Woes Darken Emergent BioSolutions' Outlook (Rating Downgrade)
Aug 14Emergent BioSolutions: Making A Big Bet On Narcan
Jul 21An Intrinsic Calculation For Emergent BioSolutions Inc. (NYSE:EBS) Suggests It's 30% Undervalued
Jun 22Is Emergent BioSolutions (NYSE:EBS) Using Too Much Debt?
Apr 05Emergent Biosolutions Q4 2022 Earnings Preview
Feb 24An Intrinsic Calculation For Emergent BioSolutions Inc. (NYSE:EBS) Suggests It's 39% Undervalued
Feb 16Emergent BioSolutions to offload travel health business to Bavarian Nordic for $380M
Feb 15Emergent BioSolutions: No Change To Thesis Following Latest Numbers, Recent Developments
Dec 07Emergent plunges 30% on quarterly earnings miss, lowers full-year guidance
Nov 09Emergent doses first participant in Phase 1 trial for Lassa virus vaccine
Sep 06Emergent BioSolutions: Now Long Through Sale Of October Put Spreads
Aug 24CEO（最高経営責任者
Joe Papa (68 yo)
less than a year
在職期間
Mr. Joseph C. Papa, Jr. also known as Joe, is Director of Milestone Pharmaceuticals Inc. since September 3, 2024. Mr. Papa serves as Executive Advisor at Water Street Healthcare Partners, LLC since joining...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Executive VP | 6.5yrs | US$2.18m | 0.29% $ 1.2m | |
| Executive Vice President of Global Quality and Ethics & Compliance | 2.4yrs | US$1.68m | 0.30% $ 1.2m | |
| Senior Vice President of Products Business | 1.7yrs | US$1.06m | 0.045% $ 182.2k | |
| CEO, President & Director | less than a year | データなし | データなし | |
| Corporate Secretary and Interim General Counsel | less than a year | データなし | データなし | |
| Senior VP & Chief Human Resource Officer | 1.5yrs | データなし | データなし | |
| Senior VP | 1.5yrs | データなし | データなし | |
| Senior VP of Science & Development | 1.7yrs | データなし | データなし | |
| Senior Vice President of Manufacturing & Bioservices | no data | データなし | 0.089% $ 360.3k |
1.6yrs
平均在職期間
58.5yo
平均年齢
経験豊富な経営陣: EBSの経営陣は 経験豊富 とはみなされません ( 1.5年の平均在職年数)。これは新しいチームを示唆しています。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| CEO, President & Director | less than a year | データなし | データなし | |
| Independent Director | 18.3yrs | US$400.23k | 0.099% $ 400.1k | |
| Independent Director | 19.7yrs | US$394.73k | 0.037% $ 148.6k | |
| Independent Director | less than a year | US$397.50k | データなし | |
| Independent Director | 2.4yrs | US$396.99k | 0.011% $ 42.9k | |
| Independent Director | 3.9yrs | US$405.98k | 0.032% $ 128.1k | |
| Independent Non-Executive Chairman | 20.1yrs | US$535.98k | 0.070% $ 285.0k | |
| Independent Director | 7.8yrs | US$413.48k | 0.069% $ 277.5k | |
| Independent Director | less than a year | US$398.75k | データなし | |
| Independent Director | 2.2yrs | US$382.23k | 0.0073% $ 29.6k |
3.2yrs
平均在職期間
65yo
平均年齢
経験豊富なボード: EBSの 取締役会 は 経験豊富 であると考えられます ( 3.1年の平均在任期間)。